Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: Report about two cases

Italian Heart Journal

Volumn 4, Issue 12, 2003, Pages 895-899

  Mafrici, Antonio ^a,c   Alberti, Antonia ^a   Corrada, Elena ^a   Ferrari, Stefano ^a   Marenna, Biondino ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

Chest pain; ST segment elevation

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOROURACIL; NITRATE; VERAPAMIL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; DISEASE MANAGEMENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; LARYNX TUMOR; MIDDLE AGED; THORAX PAIN;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; ATRIAL FIBRILLATION; CAPTOPRIL; CHEST PAIN; COLORECTAL NEOPLASMS; CORONARY ANGIOGRAPHY; DIGOXIN; DISEASE MANAGEMENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FLUOROURACIL; HUMANS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRATES; VERAPAMIL;

EID: 2142813823     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Becker K, Erckenbrecht JF, Haussinger D, Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475-84.
2. Kuropkat C, Griem K, Clark J, Rodriguez ER, Hutchinson J, Taylor AG. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Am J Clin Oncol 1999; 22: 466-70.
3. de Forni M, Malet-Martino MC, Jaillais P, et al. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 1992; 10: 1795-801.
4. Weidmann B, Jansen W, Heider A, Niederle N. 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens. Am J Cardiol 1995; 75: 194-5.
5. McKendall GR, Shurman A, Anamur M, Most AS. Toxic cardiogenic shock associated with infusion of 5-fluorouracil. Am Heart J 1989; 118: 184-6.
6. Ferrari E, Taillan B, Tibi T, et al. Toxicité cardiaque du fluorouracil. Aspects typiques et atypiques. A propos de 8 observations. Ann Cardiol Angeiol (Paris) 1992; 41: 191-5.
7. Lestuzzi C, Viel E, Picano E, Meneguzzo N. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med 2001; 111: 316-8.
8. Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993; 53: 3028-33.
9. Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994; 10: 861-4.
10. Burger AJ, Mannino S. 5-Fluorouracil-induced coronary vasospasm. Am Heart J 1987; 114: 433-6.
11. Kinhult S, Albertsson M, Eskilsson J, Cwikiel M. Antithrombotic treatment in protection against thrombogenic effects of 5-fluorouracil on vascular endothelium: a scanning microscopy evaluation. Scanning 2001; 23: 1-8.
12. Maseri A, Lanza G. Fluorouracil-induced coronary artery spasm. Am J Med 2001; 111: 326-7.
13. Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 1982; 68: 505-10.
14. Eskilsson J, Albertsson M. Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil. Acta Oncol 1990; 29: 1001-3.
15. Luwaert RJ, Descamps O, Majois F, Chaudron JM, Beauduin M. Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 1991; 12: 468-70.